71 related articles for article (PubMed ID: 15389725)
1. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen.
Miyake H; Hara I; Gleave ME; Eto H
Prostate; 2004 Dec; 61(4):318-23. PubMed ID: 15389725
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.
Sun T; Wang Q; Balk S; Brown M; Lee GS; Kantoff P
Cancer Res; 2009 Apr; 69(8):3356-63. PubMed ID: 19351832
[TBL] [Abstract][Full Text] [Related]
3. Clusterin protects mature dendritic cells from reactive oxygen species mediated cell death.
López Malizia A; Merlotti A; Bonte PE; Sager M; Arribas De Sandoval Y; Goudot C; Erra Díaz F; Pereyra-Gerber P; Ceballos A; Amigorena S; Geffner J; Sabatte J
Oncoimmunology; 2024; 13(1):2294564. PubMed ID: 38125724
[TBL] [Abstract][Full Text] [Related]
4. The Ins and Outs of Clusterin: Its Role in Cancer, Eye Diseases and Wound Healing.
Gross C; Guérin LP; Socol BG; Germain L; Guérin SL
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685987
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells.
Woods-Burnham L; Cajigas-Du Ross CK; Love A; Basu A; Sanchez-Hernandez ES; Martinez SR; Ortiz-Hernández GL; Stiel L; Durán AM; Wilson C; Montgomery S; Roy S; Casiano CA
Sci Rep; 2018 Oct; 8(1):15063. PubMed ID: 30305646
[TBL] [Abstract][Full Text] [Related]
6. Genomics of sex hormone receptor signaling in hepatic sexual dimorphism.
Zheng D; Wang X; Antonson P; Gustafsson JÅ; Li Z
Mol Cell Endocrinol; 2018 Aug; 471():33-41. PubMed ID: 28554805
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress in prostate cancer patients: A systematic review of case control studies.
Oh B; Figtree G; Costa D; Eade T; Hruby G; Lim S; Elfiky A; Martine N; Rosenthal D; Clarke S; Back M
Prostate Int; 2016 Sep; 4(3):71-87. PubMed ID: 27689064
[TBL] [Abstract][Full Text] [Related]
8. From the Cover: Sperm Molecular Biomarkers Are Sensitive Indicators of Testicular Injury following Subchronic Model Toxicant Exposure.
Dere E; Wilson SK; Anderson LM; Boekelheide K
Toxicol Sci; 2016 Oct; 153(2):327-40. PubMed ID: 27466211
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial reactive oxygen species and complex II levels are associated with the outcome of hepatocellular carcinoma.
Wu J; Zhao F; Zhao Y; Guo Z
Oncol Lett; 2015 Oct; 10(4):2347-2350. PubMed ID: 26622849
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer.
Shabayek MI; Sayed OM; Attaia HA; Awida HA; Abozeed H
Pathol Oncol Res; 2014 Oct; 20(4):859-66. PubMed ID: 24696417
[TBL] [Abstract][Full Text] [Related]
11. Targeting androgen receptor and JunD interaction for prevention of prostate cancer progression.
Mehraein-Ghomi F; Kegel SJ; Church DR; Schmidt JS; Reuter QR; Saphner EL; Basu HS; Wilding G
Prostate; 2014 May; 74(7):792-803. PubMed ID: 24647988
[TBL] [Abstract][Full Text] [Related]
12. Non-secreted clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-κB signaling pathway.
Prochnow H; Gollan R; Rohne P; Hassemer M; Koch-Brandt C; Baiersdörfer M
PLoS One; 2013; 8(9):e75303. PubMed ID: 24073260
[TBL] [Abstract][Full Text] [Related]
13. Exon-skipping strategy by ratio modulation between cytoprotective versus pro-apoptotic clusterin forms increased sensitivity of LNCaP to cell death.
Essabbani A; Garcia L; Zonetti MJ; Fisco T; Pucci S; Chiocchia G
PLoS One; 2013; 8(2):e54920. PubMed ID: 23418433
[TBL] [Abstract][Full Text] [Related]
14. Custirsen (OGX-011): clusterin inhibitor in metastatic prostate cancer.
Al-Asaaed S; Winquist E
Curr Oncol Rep; 2013 Apr; 15(2):113-8. PubMed ID: 23266703
[TBL] [Abstract][Full Text] [Related]
15. 8-Hydroxy-2'-deoxyguanosine expression predicts hepatocellular carcinoma outcome.
Li S; Wang X; Wu Y; Zhang H; Zhang L; Wang C; Zhang R; Guo Z
Oncol Lett; 2012 Feb; 3(2):338-342. PubMed ID: 22740908
[TBL] [Abstract][Full Text] [Related]
16. Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model.
Kususda Y; Miyake H; Gleave ME; Fujisawa M
Br J Cancer; 2012 Jun; 106(12):1945-52. PubMed ID: 22588555
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and prostate cancer progression are elicited by membrane-type 1 matrix metalloproteinase.
Nguyen HL; Zucker S; Zarrabi K; Kadam P; Schmidt C; Cao J
Mol Cancer Res; 2011 Oct; 9(10):1305-18. PubMed ID: 21849471
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress and DNA methylation in prostate cancer.
Donkena KV; Young CY; Tindall DJ
Obstet Gynecol Int; 2010; 2010():302051. PubMed ID: 20671914
[TBL] [Abstract][Full Text] [Related]
19. High-fat diet increases NF-κB signaling in the prostate of reporter mice.
Vykhovanets EV; Shankar E; Vykhovanets OV; Shukla S; Gupta S
Prostate; 2011 Feb; 71(2):147-56. PubMed ID: 20632379
[TBL] [Abstract][Full Text] [Related]
20. Clusterin and chemoresistance.
Djeu JY; Wei S
Adv Cancer Res; 2009; 105():77-92. PubMed ID: 19879424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
